Literature DB >> 12459464

Akt signaling mediates VEGF/VPF vascular permeability in vivo.

Isabelle Six1, Yasuko Kureishi, Zhengyu Luo, Kenneth Walsh.   

Abstract

VEGF is an endothelial cell cytokine that promotes angiogenesis and enhances microvascular permeability. Recently, it has been shown that the protein kinase Akt functions in a key intercellular signaling pathway downstream of VEGF. Here, we employed adenovirus-mediated gene transfer in conjunction with the Miles assay in hairless albino guinea pigs to assess the role of Akt signaling in vascular permeability. VEGF-induced vascular permeability was blocked by the transduction of a dominant negative mutant of Akt. Conversely, transduction of a constitutively active form of Akt promoted vascular permeability in a manner similar to VEGF protein administration. This Akt-mediated increase in vascular permeability was inhibited by the eNOS inhibitor L-NAME. These data show that Akt signaling is both necessary and sufficient for vascular permeability in an in vivo model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12459464     DOI: 10.1016/s0014-5793(02)03630-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

1.  Akt1 is critical for acute inflammation and histamine-mediated vascular leakage.

Authors:  Annarita Di Lorenzo; Carlos Fernández-Hernando; Giuseppe Cirino; William C Sessa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-21       Impact factor: 11.205

2.  Effect of bevacizumab on the tight junction proteins of vascular endothelial cells.

Authors:  Yanan Jia; Tingting Qin; Xiaoling Zhang; Shaochuan Liu; Zhujun Liu; Cuicui Zhang; Jing Wang; Kai Li
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

3.  eNOS deficiency predisposes podocytes to injury in diabetes.

Authors:  Darren A Yuen; Bailey E Stead; Yanling Zhang; Kathryn E White; M Golam Kabir; Kerri Thai; Suzanne L Advani; Kim A Connelly; Tomoko Takano; Lei Zhu; Alison J Cox; Darren J Kelly; Ian W Gibson; Takamune Takahashi; Raymond C Harris; Andrew Advani
Journal:  J Am Soc Nephrol       Date:  2012-09-20       Impact factor: 10.121

Review 4.  Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors.

Authors:  Woo-Young Kim; Ho-Young Lee
Journal:  FEBS J       Date:  2009-07-31       Impact factor: 5.542

5.  ICAM-1-mediated endothelial nitric oxide synthase activation via calcium and AMP-activated protein kinase is required for transendothelial lymphocyte migration.

Authors:  Roberta Martinelli; Matthew Gegg; Rebecca Longbottom; Peter Adamson; Patric Turowski; John Greenwood
Journal:  Mol Biol Cell       Date:  2008-12-10       Impact factor: 4.138

6.  Transforming growth factor-β regulates endothelial function during high salt intake in rats.

Authors:  Wei-Zhong Ying; Kristal J Aaron; Paul W Sanders
Journal:  Hypertension       Date:  2013-09-16       Impact factor: 10.190

7.  Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis.

Authors:  Eric Ackah; Jun Yu; Stefan Zoellner; Yasuko Iwakiri; Carsten Skurk; Rei Shibata; Noriyuki Ouchi; Rachael M Easton; Gennaro Galasso; Morris J Birnbaum; Kenneth Walsh; William C Sessa
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

8.  SCUBE3 regulation of early lung cancer angiogenesis and metastatic progression.

Authors:  Cheng-Hung Chou; Yi-Fang Cheng; Tiing Yee Siow; Amit Kumar; Konan Peck; Chen Chang
Journal:  Clin Exp Metastasis       Date:  2013-02-19       Impact factor: 5.150

Review 9.  Vascular endothelial growth factors and vascular permeability.

Authors:  David O Bates
Journal:  Cardiovasc Res       Date:  2010-04-16       Impact factor: 10.787

10.  Improved tumor vascular function following high-dose epidermal growth factor receptor tyrosine kinase inhibitor therapy.

Authors:  Mark M Moasser; Lisa J Wilmes; Ching Hang Wong; Sheye Aliu; Ka-Loh Li; Donghui Wang; Yun Kit Hom; Byron Hann; Nola M Hylton
Journal:  J Magn Reson Imaging       Date:  2007-12       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.